Denali Therapeutics DNLI
NASDAQ DNLI
$20.67 -0.14 (-0.67%)
At close: Sep 30, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Other Non-Current Assets (2017 - 2026)

Updated

Denali Therapeutics' Other Non-Current Assets was $25.83 million in Q2 2026, up 12.4% from $22.97 million a year earlier but down 1.5% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Other Non-Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Denali Therapeutics came in at $25.94 million, up 4.8% from FY2024.

  • Other Non-Current Assets has now increased for five consecutive years, with a five-year compound annual growth rate of 60.2% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Assets was $24.74 million in FY2024 (+36.4%), $18.14 million in FY2023 (+35.4%), $13.4 million in FY2022 (+12.9%) and $11.87 million in FY2021 (+382.2%).
  • Quarterly Other Non-Current Assets has moved between $3.78 million (Q3 2021) and $50.58 million (Q2 2024) over five years.
  • Compared with a year earlier, Other Non-Current Assets was higher in four of the last eight quarters, with growth averaging 11.2%.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2021 (growth of 382.2%); the worst was Q2 2025 (a decline of 54.6%).
  • Per Business Quant data, DNLI's Other Non-Current Assets in the three quarters before Q2 2026 was $26.22 million (Q1 2026), $25.94 million (Q4 2025) and $25.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Denali Therapeutics 3.30 Bn 3.30 Bn 3.51 Mn 25.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.83 Mn
Mar 31, 2026 26.22 Mn
Dec 31, 2025 25.94 Mn
Sep 30, 2025 25.11 Mn
Jun 30, 2025 22.97 Mn
Mar 31, 2025 26.93 Mn
Dec 31, 2024 24.74 Mn
Sep 30, 2024 26.49 Mn
Jun 30, 2024 50.58 Mn
Mar 31, 2024 44.62 Mn
Dec 31, 2023 18.14 Mn
Sep 30, 2023 11.14 Mn
Jun 30, 2023 14.43 Mn
Mar 31, 2023 14.02 Mn
Dec 31, 2022 13.40 Mn
Sep 30, 2022 16.12 Mn
Jun 30, 2022 15.18 Mn
Mar 31, 2022 14.21 Mn
Dec 31, 2021 11.87 Mn
Sep 30, 2021 3.78 Mn
API Access

Denali Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY